Dr. Wells is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 E Medical Ln
Ste 400
West Columbia, SC 29169Phone+1 803-794-7511Fax+1 803-794-7751
Education & Training
Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 2008 - 2011- Medical University of South CarolinaResidency, Internal Medicine, 2005 - 2008
- Medical University of South CarolinaClass of 2005
Certifications & Licensure
SC State Medical License 2010 - 2025
AL State Medical License 2007 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Publications & Presentations
PubMed
- 8 citationsA phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancerJohn H. Strickler, Christel Rushing, Donna Niedzwiecki, Abigail B. McLeod, Ivy Altomare
BMC Cancer. 2019-11-01 - 202 citationsCharacterization of Atrial Fibrillation in Man: Studies Following Open Heart Surgery*James L. Wells, Karp Rb, Nicholas T. Kouchoukos, William A.H. MacLean, Thomas N. James
Pacing and Clinical Electrophysiology. 1978-10-01 - 11 citationsCabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal CancerJohn H. Strickler, Christel Rushing, Hope E. Uronis, Michael A. Morse, Donna Niedzwiecki
The Oncologist. 2021-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
